{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:10:53Z","timestamp":1773695453738,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH GM108040"],"award-info":[{"award-number":["NIH GM108040"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["274852"],"award-info":[{"award-number":["274852"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["320136"],"award-info":[{"award-number":["320136"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005609","name":"Turun Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejphar.2020.173186","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T12:16:43Z","timestamp":1589372203000},"page":"173186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Melanocortin 3 receptor activation with [D-Trp8]-\u03b3-MSH suppresses inflammation in apolipoprotein E deficient mice"],"prefix":"10.1016","volume":"880","author":[{"given":"James J.","family":"Kadiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshav","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Kaipio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor J.","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petteri","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173186_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-3083.2005.01565.x","article-title":"Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes","volume":"61","author":"Andersen","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejphar.2020.173186_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.1999.tb08673.x","article-title":"Proopiomelanocortin and the immune-neuroendocrine connection","volume":"885","author":"Blalock","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2020.173186_bib3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/29788","article-title":"Decreased lesion formation in CCR2-\/- mice reveals a role for chemokines in the initiation of atherosclerosis","volume":"394","author":"Boring","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173186_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2007-0027","article-title":"Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases","volume":"29","author":"Brzoska","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2020.173186_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.56.1.1","article-title":"Targeting melanocortin receptors as a novel strategy to control inflammation","volume":"56","author":"Catania","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2020.173186_bib6","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1100\/tsw.2010.173","article-title":"The melanocortin system in control of inflammation","volume":"10","author":"Catania","year":"2010","journal-title":"Sci. World J."},{"key":"10.1016\/j.ejphar.2020.173186_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2217\/whe-2016-0018","article-title":"Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial","volume":"12","author":"Clayton","year":"2016","journal-title":"Wom. Health (Lond. Engl.)"},{"key":"10.1016\/j.ejphar.2020.173186_bib8","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.4049\/jimmunol.175.7.4806","article-title":"Alpha-melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status","volume":"175","author":"Cooper","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2020.173186_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(98)00318-9","article-title":"Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"143","author":"Dawson","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2020.173186_bib10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/acschemneuro.8b00346","article-title":"Insights into the allosteric mechanism of setmelanotide (RM-493) as a potent and first-in-class melanocortin-4 receptor (MC4R) agonist to treat rare genetic disorders of obesity through an in silico approach","volume":"10","author":"Falls","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173186_bib11","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.4049\/jimmunol.170.6.3323","article-title":"Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e\/e) mouse suggest an important role for melanocortin 3 receptor","volume":"170","author":"Getting","year":"2003","journal-title":"J. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2020.173186_bib12","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1007\/s000110050557","article-title":"Agonism at melanocortin receptor type 3 on macrophages inhibits neutrophil influx","volume":"48","author":"Getting","year":"1999","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2020.173186_bib13","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.4049\/jimmunol.162.12.7446","article-title":"POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation","volume":"162","author":"Getting","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2020.173186_bib14","first-page":"2234","article-title":"Melanocortin 3 receptors control crystal-induced inflammation","volume":"20","author":"Getting","year":"2006","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.ejphar.2020.173186_bib15","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1124\/mol.106.028878","article-title":"[D-Trp8]-gamma-melanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e\/e mouse)","volume":"70","author":"Getting","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173186_bib16","first-page":"1064","article-title":"Arthritic diseases: melanocortin type 3 receptor agonists as potential therapeutics","volume":"2","author":"Getting","year":"2001","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2020.173186_bib17","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/ATVBAHA.115.305348","article-title":"Both MC1 and MC3 receptors provide protection from cerebral ischemia-reperfusion-induced neutrophil recruitment","volume":"35","author":"Holloway","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2020.173186_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-5728(99)00122-8","article-title":"Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone","volume":"99","author":"Ichiyama","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2020.173186_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: a comprehensive review of studies in mice","volume":"79","author":"Kleemann","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2020.173186_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMoa1411481","article-title":"Afamelanotide for erythropoietic protoporphyria","volume":"373","author":"Langendonk","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173186_bib21","first-page":"4228","article-title":"Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion","volume":"22","author":"Leoni","year":"2008","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.ejphar.2020.173186_bib22","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.4049\/jimmunol.161.6.2873","article-title":"Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents","volume":"161","author":"Manna","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2020.173186_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.peptides.2005.01.025","article-title":"The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R)","volume":"27","author":"Marks","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2020.173186_bib24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.105.543579","article-title":"CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study","volume":"112","author":"McDermott","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2020.173186_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/JOE-17-0636","article-title":"Melanocortin overexpression limits diet-induced inflammation and atherosclerosis in LDLR-\/-mice","volume":"236","author":"Nuutinen","year":"2018","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2020.173186_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2567.2011.03497.x","article-title":"CD4+ T helper 2 cells--microbial triggers, differentiation requirements and effector functions","volume":"134","author":"Okoye","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.ejphar.2020.173186_bib27","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1161\/ATVBAHA.114.305064","article-title":"Deficiency in melanocortin 1 receptor signaling predisposes to vascular endothelial dysfunction and increased arterial stiffness in mice and humans","volume":"35","author":"Rinne","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2020.173186_bib28","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1161\/ATVBAHA.118.311185","article-title":"Palmitoylethanolamide promotes a proresolving macrophage phenotype and attenuates atherosclerotic plaque formation","volume":"38","author":"Rinne","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2020.173186_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/ATVBAHA.117.310418","article-title":"Melanocortin 1 receptor deficiency promotes atherosclerosis in apolipoprotein E-\/-Mice","volume":"38","author":"Rinne","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2020.173186_bib30","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1038\/s41598-018-33523-7","article-title":"Pro-opiomelanocortin and its processing enzymes associate with plaque stability in human atherosclerosis - tampere vascular study","volume":"8","author":"Rinne","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173186_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/CIRCULATIONAHA.116.025889","article-title":"Melanocortin 1 receptor signaling regulates cholesterol transport in macrophages","volume":"136","author":"Rinne","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2020.173186_bib32","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/ATVBAHA.113.302963","article-title":"Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice","volume":"34","author":"Rinne","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2020.173186_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molmet.2018.11.011","article-title":"CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice","volume":"20","author":"Riopel","year":"2019","journal-title":"Mol. Metab."},{"issue":"Suppl. l","key":"10.1016\/j.ejphar.2020.173186_bib34","doi-asserted-by":"crossref","first-page":"S382","DOI":"10.1194\/jlr.R800032-JLR200","article-title":"Mechanisms and consequences of macrophage apoptosis in atherosclerosis","volume":"50","author":"Seimon","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2020.173186_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173186_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.107.161174","article-title":"Chemokines in atherosclerosis: an update","volume":"28","author":"Zernecke","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:09:45Z","timestamp":1762142985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920302788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":36,"alternative-id":["S0014299920302788"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173186","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanocortin 3 receptor activation with [D-Trp8]-\u03b3-MSH suppresses inflammation in apolipoprotein E deficient mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"173186"}}